Healthcare ยท National
Gilead signs generic licensing deals for experimental Ebola drug
A late-stage trial is testing the drug in people at high risk after exposure. The deals are intended to line up manufacturing and supply before trial results and regulatory filings
Verified Timeline
No verified timeline updates.
What is your view on โGilead signs generic licensing deals for experimental Ebola drugโ?
This is self-selected reader participation, not representative scientific polling.

